Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study.

Federico TacconiGiuseppe MangiameliEmanuele VoulazAlexandro PatirelisFederica CarleaEleonora La RoccaAlessandro TamburriniGianluca VanniVincenzo Ambrogi

Published in: Journal of clinical medicine (2023)

blood-derived inflammation markers had no value in the preoperative prediction of nodal status. Nevertheless, our results might suggest a modulating effect of platelet-derived inflammation markers on nodal progression after the resection of tumors larger than 2 cm.

Keyphrases

oxidative stress
lymph node
neoadjuvant chemotherapy
patients undergoing
signaling pathway